Fuse Medical, Inc.
FZMD
$0.0899
-$0.01-10.01%
| Weiss Ratings | FZMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | FZMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | FZMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.51 | |||
| Price History | FZMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -10.01% | |||
| 30-Day Total Return | 47.38% | |||
| 60-Day Total Return | -10.01% | |||
| 90-Day Total Return | 12.38% | |||
| Year to Date Total Return | 20.03% | |||
| 1-Year Total Return | -16.37% | |||
| 2-Year Total Return | 197.68% | |||
| 3-Year Total Return | -61.25% | |||
| 5-Year Total Return | -83.65% | |||
| 52-Week High % Change | -25.02% | |||
| 52-Week Low % Change | 461.88% | |||
| Price | FZMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.12 | |||
| 52-Week Low Price | $0.02 | |||
| 52-Week Low Price (Date) | Nov 04, 2024 | |||
| 52-Week High Price (Date) | Dec 10, 2024 | |||
| Valuation | FZMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 6.50M | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | 2.48 | |||
| Earnings Per Share (TTM) | 0.04 | |||
| Earnings Per Share Growth | -237.64% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.38 | |||
| Price/Book (Q) | -27.24 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.09 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | FZMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 78.03M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | FZMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 469 862 3030 | |||
| Address | 1565 North Central Expressway Richardson, TX 75080 | |||
| Website | www.fusemedical.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | FZMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -1.30% | |||
| Profit Margin | 19.71% | |||
| Management Effectiveness | FZMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -0.78% | |||
| Return on Equity | -- | |||
| Income Statement | FZMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 18.40M | |||
| Total Revenue (TTM) | 18.40M | |||
| Revenue Per Share | $0.24 | |||
| Gross Profit (TTM) | 11.95M | |||
| EBITDA (TTM) | -57.00K | |||
| EBIT (TTM) | -239.70K | |||
| Net Income (TTM) | 3.63M | |||
| Net Income Avl. to Common (TTM) | 3.63M | |||
| Total Revenue Growth (Q YOY) | 7.05% | |||
| Earnings Growth (Q YOY) | 195.26% | |||
| EPS Diluted (TTM) | 0.04 | |||
| EPS Diluted Growth (Q YOY) | 184.78% | |||
| Balance Sheet | FZMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 253.40K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 12.82M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -231.60K | |||
| Current Ratio (Q) | 1.063 | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | 19.32M | |||
| Total Current Liabilities (Q) | 12.06M | |||
| Total Debt (Q) | 2.22M | |||
| Total Liabilities (Q) | 19.55M | |||
| Total Common Equity (Q) | -231.60K | |||
| Cash Flow | FZMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 423.00K | |||
| Cash from Financing (TTM) | -369.30K | |||
| Net Change in Cash (TTM) | -350.60K | |||
| Levered Free Cash Flow (TTM) | 1.17M | |||
| Cash from Operations (TTM) | -404.30K | |||
